Skip to content
PEPLUX

Tuftsin-derived synthetic peptide

Selank

Also called TP-7.

Illustrative PEPLUX product vial in a purple-lit studio
Product illustration

Product form

Nasal spray or subcutaneous injection

The process

Licensed provider review

Selank cost

$229 per month

*If medically eligible.
Medication
Included
Clinician visit
Included
Baseline labs
Included
Lab retests
Included when ordered by your provider
Shipping
Included
Patient portal access
Included
Care-team chat support
Included

Considering more than one product?

  • Two products prescribed together: $349 per month
  • Three products prescribed together: $479 per month
Compare pricing

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.

FDA status, checked on October 13, 2026

Selank is not FDA-approved, and there is no lawful pathway for a US pharmacy to compound it today. Its safety and effectiveness in people have not been established.

Order now

No compounding pathway today.

*If medically eligible.

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.

PEPLUX is a telehealth platform, not a pharmacy or drug manufacturer. Medications are compounded and dispensed by independently licensed US compounding pharmacies.

Prescription products require an online evaluation with a licensed provider. Not all patients qualify.

States served: not yet confirmed. How state availability works

What is Selank?

Selank acetate (TP-7).

Adults who want to discuss selank with a licensed provider and who understand that it is not FDA-approved and that the evidence in people is limited. Whether it is appropriate is a decision made with the prescriber after an evaluation, not a choice made from this page.

Key risks

  • Selank is not FDA-approved, and its safety in people has not been established.
  • FDA's safety page says compounded selank acetate may pose a risk of immunogenicity, an immune reaction to the peptide, and that FDA lacks important information on its safety in people.
All risks and who should not use it

FDA status

FDA status for Selank.

Rendered from our regulatory records, which cite FDA, Federal Register and label documents directly. Each record shows the date we last checked it.

No compounding pathway today.

Selank is not FDA-approved, and there is no lawful pathway for a US pharmacy to compound it today. Its safety and effectiveness in people have not been established.

Selank

No compounding pathway today.

FDA’s documents list it as Selank acetate (TP-7).

Selank is not FDA-approved, and there is no pathway for a US pharmacy to compound it today. FDA removed it from its 503A Category 2 on September 27, 2024, because the nominator had meant to nominate a different substance. FDA's Pharmacy Compounding Advisory Committee has not reviewed it, and nothing is pending.

Basis
FDA's 503A categories document of September 27, 2024 removed selank from Category 2 because the nominator meant to nominate a different bulk drug substance. It has no entry in FDA's current 503A or 503B category documents, it is not on the 503A bulks list (21 CFR 216.23) or the 503B bulks list, and it is not a component of an FDA-approved drug. FDA's safety page says compounded selank acetate may pose a risk of immunogenicity and that FDA lacks important information on any safety issues it raises in people.
Checked on
October 13, 2026

How it works

Selank mechanism.

Selank is a synthetic peptide of seven amino acids. It is built on tuftsin, a four-amino-acid fragment of an immunoglobulin, with a short proline-glycine-proline extension added to slow its breakdown in the body. Laboratory and animal research has looked at its effects on neurotransmitter signaling, on enzymes that break down enkephalins, and on the expression of immune signaling molecules.

That describes what the molecule does in the body. It is not a claim about what it will do for you.

What the evidence supports

Selank: evidence and limitations.

Most published research on selank is in animals and cell systems. Human studies are few and small, and none establishes its safety or effectiveness in people.

Risks

Selank risks and side effects.

  • Selank is not FDA-approved, and its safety in people has not been established.
  • FDA's safety page says compounded selank acetate may pose a risk of immunogenicity, an immune reaction to the peptide, and that FDA lacks important information on its safety in people.
  • Side effects have not been characterized in large studies. Route-related effects are possible, such as irritation inside the nose with nasal use or reactions at the injection site.
  • There is no FDA label, so there is no formal list of contraindications. It should not be used during pregnancy or breastfeeding, where there are no safety data.

This information is educational and is not medical advice. It does not establish a provider–patient relationship.

Clinical review

What your prescriber will consider.

These are decision factors a licensed provider weighs when deciding whether this product is appropriate for you. They are not instructions, and there is no dosing protocol on this page.

  • Current medicines, especially any that act on the nervous system

  • Any prior allergic or immune reaction to a peptide product, and any immune condition, given FDA’s note on immunogenicity

  • Whether the concern behind the request has had a standard medical evaluation, and any established treatment already in use

  • Which offered route suits the person, nasal or subcutaneous

  • Pregnancy, breastfeeding or plans to conceive

PEPLUX does not publish self-administration protocols. Dose, frequency and duration are set by your prescriber against your own history and reviewed over time.

Lot documents

What a certificate of analysis should cover.

When a pharmacy is named, each lot's certificate of analysis is expected to cover the tests below. No certificate exists or is published yet.

  • Potency
  • Sterility
  • Endotoxin
  • pH

Sport and anti-doping

WADA status.

  • Not named on the WADA 2026 Prohibited List. Not named on the 2026 list. Whether the S0 class (substances with no government approval for human therapeutic use) reaches it has not been confirmed.

The list is revised every year. If you compete, check the current list and your federation’s own rules.

Straight answers

Common questions about Selank.

What is the FDA status of Selank?
No compounding pathway today. Selank is not FDA-approved, and there is no pathway for a US pharmacy to compound it today. FDA removed it from its 503A Category 2 on September 27, 2024, because the nominator had meant to nominate a different substance. FDA's Pharmacy Compounding Advisory Committee has not reviewed it, and nothing is pending. Checked against primary sources on October 13, 2026.
Is compounded Selank an approved drug?
No. Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Selank is not FDA-approved, and there is no lawful pathway for a US pharmacy to compound it today. Its safety and effectiveness in people have not been established. PEPLUX is a telehealth platform, not a pharmacy or drug manufacturer. Medications are compounded and dispensed by independently licensed US compounding pharmacies.
What does the evidence support for Selank, and what does it not?
Most published research on selank is in animals and cell systems. Human studies are few and small, and none establishes its safety or effectiveness in people.
What are the risks of Selank?
Selank is not FDA-approved, and its safety in people has not been established. The full list of side effects, and of who should not use Selank, is in the risks section of this page. Your prescriber reviews your history before deciding whether it is appropriate for you.
Does Selank require baseline labs?
No. Selank does not require baseline labs, though your prescriber may order them based on your history. Baseline labs are included in the price.
What does Selank cost?
$229 per month. Medication: included. Clinician visit: included. Baseline labs: included. Lab retests: included when ordered by your provider. Shipping: included. Patient portal access: included. Care-team chat support: included. *If medically eligible.
Is Selank prohibited in sport?
Not named on the WADA 2026 Prohibited List. Not named on the 2026 list. Whether the S0 class (substances with no government approval for human therapeutic use) reaches it has not been confirmed.
How is Selank given?
Nasal spray or subcutaneous injection. Your prescriber decides whether it is appropriate for you and sets the regimen. PEPLUX does not publish dosing.

Next step

A licensed provider reviews every request.

Selank is not FDA-approved, and there is no lawful pathway for a US pharmacy to compound it today. Its safety and effectiveness in people have not been established.

Order now

No compounding pathway today.

*If medically eligible.

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality.

Also offered

Other products.

All productsFDA status tracker